Evaluating Ovid Therapeutics: Insights From 6 Financial Analysts
In the latest quarter, 6 analysts provided ratings for Ovid Therapeutics (NASDAQ:OVID), showcasing a mix of bullish and…
Nasdaq Surges Over 200 Points; Aaron’s Shares Jump
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging over 200 points on…
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Mustang Bio (NASDAQ:MBIO) stock moved upwards by 307.9% to $0.53 during Monday’s regular session. The company’s market…
Crude Oil Rises 1%; Mustang Bio Shares Spike Higher
U.S. stocks traded mixed midway through trading, with the S&P 500 edging higher on Monday. The Dow traded…
US Stocks Mixed; Dow Tumbles Over 100 Points
U.S. stocks traded mixed this morning, with the Dow Jones index falling more than 100 points on Monday.…
What’s Going On With Ovid Therapeutics After Takeda’s Two Phase 3 Epilepsy Studies Fail?
Takeda Pharmaceutical reveals Phase 3 study data for Soticlestat (TAK-935) in treating Dravet and Lennox-Gastaut syndromes. In 2021, Ovid Therapeutics out licensed the drug.
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) rose sharply in today’s pre-market trading after the company announced results from…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 77.4% to $6.19 during Monday’s pre-market session. The company’s market…
Cracking The Code: Understanding Analyst Reviews For Ovid Therapeutics
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Ovid Therapeutics…